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Introduction
In order to illustrate the type of studies we address in this paper, let us consider the Stanford heart transplant data set previously analyzed by, e.g., Crowley and Hu (1977) and Kalbfleisch and Prentice (1980) . The data set consists in survival times of potential heart transplant recipients after their acceptance into the Stanford heart transplant program. The choice of heart recipients is not randomized in the program. In such an observational study, background characteristics affecting both treatment assignment and survival time must be controlled for when evaluating the effect of heart transplantation. One of the peculiarities of the Stanford program, which complicates the analysis (see Keiding, 1995) , is that individuals may change treatment status during the follow-up time, being first control (not transplanted) and later treated (transplanted). Thus, survival times are censored due both to external reasons (e.g., end of study, drop out) and to internal reasons (treatment).
In this paper, we study the non-parametric estimation of a treatment effect in studies of the Stanford program type. Following Fredriksson and Johansson (2004) we estimate survival functions on a treated and a control group which are made comparable through matching on observed covariates. We contribute by developing a formal framework that allows us to show the unbiasedness of the matching estimator utilized. We also provide an estimator for its variance. This is done by building on the potential outcome framework, which was introduced by Neyman (1990 Neyman ( , translation of a text published in 1923 in the context of randomized experiments, and adapted to observational studies by Rubin (1974) ; see also Holland (1986) for a review. We perform inference by conditioning on waiting time to treatment, that is time between the entrance in the study and treatment. This can be done only when sufficient data is available. In other cases, averaging over waiting times is a possibility, although the classical interpretation of the estimated survival functions is lost unless hazards are not functions of the waiting times.
Our approach does not make parametric or distributional assumptions. In particular, we do not assume proportionality of the hazards compared, which is equivalent to a constant multiplicative treatment effect. Other matching estimators have been proposed in the literature for similar situations, see, e.g., Lechner (1999) and Sianesi (2004) . However, none of these consider the estimand we are interested in, namely the difference in survival function obtained from taking or not taking treatment. An exception, however, is Heller and Venkatraman (2004) where a non-parametric test of the no-treatment effect hypothesis is presented. Their proposal does, however, not allow for the actual estimation of a treatment effect. Also related to our work is the large literature on parametric modelling for the estimation of a treatment effect on survival times, see, e.g., Robins (1999) , Hernán, Brumback and Robins (2001) and Abbring and van der Berg (2003) . For instance, Robins and co-authors also use a potential outcome framework although focusing on parametric modelling of the data generating mechanism. The parametric approach has the advantage of being able to deal with more complex situations such as, e.g., the application of sequences of treatments. This is achieved, however, at the price of imposing structure (stronger assumptions) on the data generating mechanism.
Observational studies of the Stanford program type may be found in other fields than medical applications, including labour economics, where the interest often lies on the estimation of the effect of a training program (treatment) on, e.g., unemployment duration. Such a study is presented in Section 5. While we have found the Stanford heart transplant study to be appropriate as a red thread to illustrate the concepts and methods developed in the paper because of its simplicity and previous use in the literature, the case study of Section 5 is a more realistic application, because of the richness of background information on the individuals. Moreover, the large number of individuals in the study allows us to conduct inference conditionally on waiting time.
The remainder of the paper is organized as follows. The next section describes the inferential issues of interest on an intuitive level. Section 3 presents the potential outcome framework and its associated Neyman's inference, and generalizes it to survival time outcomes. For non-censored real valued outcomes this approach has a long history for observational studies, see, e.g., Cochran and Rubin (1973) , Rubin (1973a Rubin ( , 1973b Rubin ( , 1990b , and Rubin (1984, 1985) . In Section 4 the treatment effects of interest are defined. These are basically differences in hazard and survival functions for the treated and the controls. These functions are made comparable through matching on observed covariates while conditioning on waiting time to treatment. Thus, matching estimators are used. They are shown to be unbiased and an estimator of their variance is deduced. In Section 5, we use a large data-set on Swedish unemployed and estimate the effect of an employment subsidy on their unemployment duration. In Section 6, a Monte Carlo study is conducted to analyze the finite sample performance of the proposed estimators and a corresponding test of no treatment effect. Finally, the paper is concluded in Section 7.
Matching treated with controls
We, purposely, begin by presenting the inferential issues on an intuitive level and delay its formal justification to Section 3 and 4 in order to improve the readability of the paper. We use the Stanford study described in the introduction as background for the discussion. The survival times of the individuals in the study are schematically displayed using Lexis diagrams in Figure 1 . In Panel A of the figure, survival times of treated individuals, i.e., patients having received a heart transplant, are represented. Survival times without treatment, i.e. for control individuals, are displayed in Panel B. Note that individuals of Panel A are also included in Panel B since treated patients are not treated until they obtain treatment. Treatment assignment is not made at entrance in the study but only when a heart becomes available. Hence, deleting treated patients from the control group would imply a conditioning on survival outcomes, thereby yielding a biased analysis.
In both panels, the x-axis represents calendar time with the origin at the beginning of the study, while the y-axis represents time with origin at the time patients are treated in Panel A, and at the time patients enter the study in Panel B. Treatment assignments are represented by an open circle in both panels. The diagonal lines represent the history of each patient, starting with their entrance in the study and finishing with death (denoted with a filled circle) or censoring. The solid part of the line highlights the survival time (outcome) of interest, while the dashed part of the line is part of the survival history, however, not part of the outcome.
We want to know which controls can be compared to which treated in order to evaluate the effect of the treatment on the survival times (solid diagonal lines). Randomized treatment: Assume first that treatment is randomized, that is each time a heart transplant can be performed a patient is randomly chosen for treatment from those still alive. Then, in contrast with usual randomized studies, the treated and controls cannot directly be compared, because on average the observed survival durations after transplantation are shorter than the survival durations for the controls. This problem can be corrected by conditioning inference on waiting time. For that purpose, you consider all patients having been transplanted after a given waiting time W , and use as a control group all those that have survived and have not been treated until time W . This is illustrated in the Lexis diagrams of Figure 1 for the first patient to receive a transplantation in Panel A. She/he has waited time W before being treated and, therefore, controls for this treated patient are all those patients passing the horizontal dotted-dashed line alive and untreated in Panel B.
Observed treatment: Randomization of the treatment is seldom possible for ethical and/or practical reasons. In the Stanford heart transplant program there was no randomization of treatment (e.g., donors and patients must be compatible) and, therefore, one should not only condition for the waiting time W but also match for other pretreatment characteristics. In this context, the crucial assumption is that conditional on waiting time and the observed pre-treatment characteristics affecting both the treatment and the outcome, the treatment assignment can be considered as randomized-like, see Rosenbaum and Rubin (1983) . This assumption is sometimes called unconfoundedness assumption. Thus, for a patient having been transplanted, a control having survived until time W without being treated is selected such that her/his pre-treatment characteristics are similar to the treated. This is a so called matching procedure to construct a relevant control group; see, e.g., Rubin (1973a Rubin ( ,1974 . Estimation of a treatment effect: When a control group is constructed by a matching procedure −we call such a group a matched control group in the sequel−, it remains to compare survival times for the treated with the survival times for the controls. Average survival times cannot be estimated because censoring arises in both groups. On the other hand, hazards of death and survival functions can be computed and compared for both groups. An extra difficulty arises in the control group since patient's survival may not only be censored by an external mechanism (such as the end of the study) but also by the fact that some controls receive treatment. However, we show in the next section that, under certain conditions, the unconfoundedness assumption yields that the censoring due to treatment is independent of the outcome when conditioning on pre-treatment characteristics.
3 Inferential framework:
3.1 Potential outcome specification Potential outcomes were introduced by Neyman (1990) in the context of randomized experiments as a framework to perform inference on treatment effects. Rubin (1974) generalized their applicability to the context of observational studies. We adapt below the potential outcome framework to the context described in the previous section.
For an individual which, up to time W, has both survived and has not been treated, we define two potential outcomes: We, further, denote by X the vector of pre-treatment characteristics, and by
the treatment indicator. While, in general, X and D(W ) are observed, at most one of the two potential outcomes T 0 (W ) or T 1 (W ) can be observed for a given individual having survived until time W . As an example, we summarize in Table 1 the observed status of the variables for a subset of individuals from the Stanford heart transplant study given the waiting time W = 21.
We make a first assumption, often called the stable-unit-treatment-value assumption; see, e.g., Rubin (1990b) .
Assumption A: The values T 1 (W ) and T 0 (W ) for a given individual are not affected by the values taken by D(W ) for any other individual.
Inference
Assume now that at a given time W in a study, n 1 individuals are treated, indexed by i = 1, 2, . . . , n 1 . A certain amount of individuals (often ≫ n 1 ) have also survived until time W although they are not treated at that time, thereby providing a reservoir of controls. A matched control group is extracted from this reservoir as described in Section 2, indexed by i = n 1 + 1, . . . , 2n 1 . In this paper, we focus on estimands of the following type:
i.e. the average treatment effect for treated patients and their match in the control group for a given waiting time. Other type of estimands based on different populations may be considered, see Rubin (1991) and Imbens (2004) . For instance, one may be interested in "the average treatment effect for a future patient exposed to treatment, where treatment is assigned with p(X, W ) at a given time W ". The latter is defined on an implicit superpopulation. The information available in the observed sample on ∆(W ) is also all the information we have on the estimand defined on the super-population. Moreover, for an unbiased estimator of ∆(W ) to be an unbiased estimator of the second estimand, we need to further assume that the patients in the study are representative (e.g., a random sample) of the super-population implicitly defined. Yet another estimand of interest might be "the average treatment effect for a future patient on which treatment is imposed at a given waiting time W ". This is again a super-population estimand. All the estimands described are equivalent if we have constant additive treatment effect, i.e.
Notice that the constant additive treatment effect assumption is often made, for instance, when using Cox regression models. We do not make such a restrictive assumption in the sequel.
To perform inference, we need a probability model. Several models and resulting modes of inference may be entertained, see Rubin (1990b Rubin ( , 1991 . In any case, a model for the treatment assignment mechanism is the corner stone to the identifiability of the estimand of interest. That is a specification of Pr(D(W ) = 1|X, T 1 (W ), T 0 (W )) the probability of being treated when the waiting time has been W . The following two assumptions are often made within the potential outcome framework.
Assumption B: The assignment mechanism D(W ) is independent of the potential outcomes, conditional on the set of pre-treatment characteristics X, i.e., Pr(
is a function of (X, W ) only; see Dawid (1979) for an account on conditional independence statements.
Assumption C: 0 < p(X, W ) < 1. Assumption B is sometimes called the unconfoundedness assumption. Assumption C states that each individual having survived without being treated until time W has nonzero probability of being both treated and not treated at time W . Assumption B and C together were termed strong ignorability of the treatment assignment by Rosenbaum and Rubin (1983) . They guarantee that a treated and a control individual having the same value for X (a matched pair) can be compared in order to infer a treatment effect.
If we would have uncensored survival times, an estimator of ∆(W ) would be
where we assume that individual i + n 1 is a match to individual i, i = 1, . . . , n 1 . The properties of the statistic (1) can be studied by considering its sampling distribution under treatment reassignments through p(X, W ) for fixed values of
. . , 2n 1 , with the constraint that within each matched pair both treatment and nontreatment arise. Under this assignment mechanism, over the 2n 1 n 1 randomizations, we 7 have unbiasedness (Neyman, 1990 , Rubin, 1990a : E{ ∆(W )} = ∆(W ). If, moreover, we have constant additive treatment effect, then (Neyman, 1990 )
is an unbiased estimate of the variance of ∆(W ). Otherwise, if the treatment effect is not constant additive, then this variance estimator is conservative. This mode of inference dates back to Neyman (1990) and is called by Rubin (1990b) randomizationbased repeated-sampling inference; see also the Appendix.
Survival analysis 4.1 Hazards: estimand and estimators
The estimator ∆(W ) above cannot be computed, because the survival times of the observed individuals are censored. Controls can be censored by treatment and both controls and treated can be censored, for instance, by the end of the study period. In such situations, it is customary to use the survival analysis approach, see, e.g., Kalbfleisch and Prentice (1980) . Assumptions on the censoring mechanisms must be made, however.
First, we want censoring due to treatment after time W to be independent of the potential outcome T 0 (W ) conditional on X. To shed light on this issue let C T (W ) denote the time to treatment for an individual not treated at time W . By convention
In order to be able to take advantage of Assumption B we assume that the following decomposition holds.
Assumption D says that treatment assignments at different times (after time W ) are independent of previous assignment when conditioning on X and T 0 (W ). Under this assumption and Assumption B, we can then write
By the latter equality we see that with Assumptions B and D we obtain a censoring mechanism due to treatment which is independent of the potential outcome T 0 (W ) when conditioning on X.
Let us now define the variable C E (W ), the time to censoring (by other reasons than treatment, e.g. end of study and drop out) for an individual having survived until time W . Then, the observed survival time is censored depending on whether
We make the following assumption.
Assumption E corresponds to usual hypotheses of independent censoring mechanism made in survival analysis. We restrain here to introduce a new notation to denote censored potential outcomes. Thus, in the sequel, T j (W ), j = 0, 1, denotes time to death or to censoring.
In a survival analysis approach, instead of comparing the average survival times, ∆(W ) above, the sample hazards (proportion of individuals dying at time t among those having survived up to time t) are compared for the treated and controls. We therefore consider the estimand
where
, for j = 0, 1.,
if the individual has survived and is not censored until time t, and I(T ≥ t) = 0 otherwise. Also, I(T = t) = 1 if T = t because of death (not censoring) and I(T = t) = 0 otherwise. Estimand ∆ h (t; W ) and its building blocks h j (t; W ), j = 0, 1, are defined with respect to the potential outcomes which have been censored. Another estimand could have been defined based on the uncensored potential outcomes. Our focus on the censored version is justified by Assumption E and by (3), consequence of Assumptions B and D, which together guarantee that the ∆ h (t; W ) defined under censoring is representative (in a frequentist sense) of the same estimand without censoring. Note, moreover, that under a zero constant additive treatment effect,
, for all i, the estimands with and without censoring are equivalent.
Estimand ∆ h (t; W ) can be estimated with
, for j = 0, 1.
We show in the Appendix that, under the Assumptions A-C, ∆ h (t; W ) is unbiased for ∆ h (t; W ): E{ ∆ h (t; W )} = ∆ h (t; W ). Moreover, the variance of the estimator ∆ h (t; W ) can be estimated with
This estimator is unbiased, for instance, when there is no treatment effect in the sense that
In general, however, it is positively biased (yielding conservative inference); see the Appendix. This is a qualitatively different result from that of Neyman (1990) , where unbiasedness of the variance estimator (2) is guaranteed under constant additive treatment effect. This difference is due to the fact that the hazard is based on indicator functions of the survival times and not on the times themselves.
Survival function
The survival function, the proportion of individuals surviving at least up to time t, constitutes a convenient way to summarize or aggregate the information from the hazards calculated above. Denote by T 
Similarly, we define the survival function when not treated by
are the m 0 ≤ 2n 1 not censored survival times if not treated, sorted in ascendant order. We are, thus, interested in estimating the difference
An estimator of ∆ s (t; W ) is readily available by replacing the hazards by their estimators described above, as follows
are the m 1 ≤ n 1 observed and not censored survival times for the treated individuals, and
are the m 0 ≤ n 1 observed and not censored survival times for the matched control individuals. These estimators of the survival functions are usual Kaplan-Meier estimators (Kaplan and Meier, 1958) .
The asymptotic variance of the estimated survival functions can be estimated by, for j = 0, 1,
, see Kaplan and Meier (1958) . The above expression is called the Greenwood's formula (Greenwood, 1926) . Finally, the estimator based on this asymptotic approximation V ar{ ∆ s (t; W )} = V ar{ F 1 (t; W )} + V ar{ F 0 (t; W )} is, as in Section 4.1, expected to be conservative when the treatment effect is not exactly zero for all individuals. The simulation study of Section 6 shows that this estimated variance can be useful to test the hypothesis of no treatment effect.
Averaging over waiting times
The theory above has been developed for a fixed waiting time to treatment, W . However, estimating the survival functions non-parametrically for a given waiting time assumes the availability of sufficiently many observations at each waiting time W of interest. This is not always the case as, e.g., with the Stanford heart transplant data. In such cases, one may average over the observed waiting times yielding the new estimand
, for j = 0, 1, and now i = 1, . . . , N 1 indexes all the treated individuals in the study, and i = N 1 + 1, . . . , 2N 1 indexes all the corresponding match controls. This is the average treatment effect for treated patients and their match in the control group. The corresponding estimator is obtained by considering all individuals in the treated-matched sample instead of only those with a given waiting time. This estimand and estimator have a clear interpretation (average difference in hazard). However, ∆ s (t) obtained by "plugging in" h j (t), j = 0, 1, in (6) and (5), is difficult to interpret unless the hazards h j (t; W ), j = 0, 1, are not functions of W . On the other hand, interpretability of ∆ s (t) is less of an issue if the main objective of the analysis is to test the hypothesis of no treatment effect. Finally, computing and estimating the variance of such an estimator is difficult since some treated may be used as control. However, in cases where such double use of the same individual is rare (e.g., many untreated controls are available) the variance provided in the previous section may be used as an approximation when averaging over waiting times.
The Stanford heart transplant program
We replicate the analysis of Crowley and Hu (1977) based on the Cox proportional hazard model. They model the hazard for patient i with
where h(t i ) is the baseline hazard and Z(t i ; W i ) = I(t i ≥ W i ), the heavy side function. We use exact partial maximum likelihood to estimate the parameters of model (9), where the vector X i contains age when eligible and year of acceptance into the study. Information on prior surgery is not included because it was found not significant. The estimate ∆ s (t) is displayed in Figure 2 . The estimation is obtained by one to one matching. That is for each treated a control is chosen by matching exactly on year of acceptance and waiting time to transplant, while matching on the age when eligible on a nearest neighbor (Euclidean distance) basis. The nearest neighbor must not be more than four years apart. This restricts the sample to 60 treated and matched control individuals. Together with ∆ s (t) we display in Figure 2 the difference in survival functions resulting from the fitted Cox proportional hazard model described above. We do not display the 95% confidence bands to improve readability. They clearly include zero. However, since the number of controls is not large compared to the number of treated, the variance estimator is not reliable as noted in Section 4.3.
Model (9) assumes proportionality of the hazards with and without treatment. Moreover, both the parametric and the matching estimators must assume that hazard functions do not to depend on W due to the small sample available. This together with the fact that there is little background information on patients make the evaluation of the transplantation effect difficult.
Effect of an employment subsidy program
To illustrate the use of the non-parametric estimator with a realistic application we use Swedish register data to evaluate the effect on employment of an employment subsidy program targeted at the long-term unemployed. Individuals are eligible for the subsidy if they are at least 25 years-of-age and have been registered as unemployed at the public employment service (PES) for at least 12 months without interruption. The subsidy amounted to 50 percent of total wage costs and was paid for a maximum period of 6 months. The subsidy was also capped at 350 Swedish crowns per day and could be extended to 12 months in some exceptional cases; see Forslund, Johansson and Lindqvist (2004) . Register data from the Swedish National Labour Market Board is used to evaluate this program. The database contains information on all individuals registering at the PES in Sweden since August 1991, including, age, sex, educational attainment, the individuals' registration date and past job training activities.
The individuals in the data are classified into two different groups: those who start the employment subsidy program after having become eligible and eligibles who do not start the program. The study start on January 1998. Each time a person becomes eligible, the duration (months) until she or he either finds an employment or becomes right censored (end of study on October 1 2002, drop out) is recoded. A total of 631,358 individuals, aged 25-63, were eligible for the program during the study period. Three percent of the eligible spells ended into the program. The most salient feature of the eligible persons is that they, on average, had a long lasting relationship with the employment service; see Forslund et al. (2004) for more details.
To obtain ∆ s (t; W ) and ∆ s (t) we use one to one exact matching. For each participant we look for one control (non-participant) which has exactly the same values for a set of covariates: sex, Nordic citizenship, unemployment insurance, disabled, high school degree, university degree−all binary−, age (≤ 30, 31-40, 40-50) , number of previous days in unemployment register (0, 1-100, 101-500, 501-1000, >1000), number of previous spells in unemployment register (0, 1-5,6-15), and the local labour market of the individuals (Sweden is divided into 100 local labour markets). All these covariates are expected to affect both the unemployment duration and the participation into the program. The matching estimator is based on 7, 651 treated individuals, thus 12, 300 people in the employment subsidy program are removed due to lack of common support (no matching individual found in the control group).
This study does not suffer of the limitations of the Stanford heart transplant program. Because we have many observations (7, 651) we are able to estimate treatment effects by conditioning on W . Moreover, we have few treated (3%) and, therefore, only 265 individuals in the matched control group also belongs to the treated group. This allows us to use the variance calculations of Section 4.2 for the estimator ∆ s (t). Note that here right censoring concerns 51% of the sample. There are few drop-outs, see Forslund et al. (2004) for more details on those.
Thus, Figure 3 shows the estimated treatment effects ∆ s (t) and the estimated treatment effects ∆ s (t; W ) for W = 1, 11, 21 and, 31. In all cases 95% confidence bands (based on a normal approximation) are also displayed to judge significance.
The conditional (on waiting time) results are similar which indicates that the hazards are fairly constant with respect to waiting time. This enables us to focus our discussion on the average estimate. We see that after an initial period of about 6 months with a negligible (negative) program effect there is an downward jump; from then on the effect gradually becomes smaller, but it is positive (i.e., the program shorten unemployment duration) and significant over the rest of the follow-up horizon (57 months). This scenario is consistent with an initial period of locking in effect (i.e. individuals do not find a job while being in the program −they are supposed to seek non-subsidized employment while into the program) and a subsequent period with a positive program effect. The sum of the effects over the whole follow-up horizon is 7.8, i.e. we have an average decrease in unemployment duration (from the entrance into the program) by almost 8 months.
6 Monte Carlo study
Design
We study here the small sample performance of the matching estimators studied in this paper. To this end we generate geometrically distributed survival times. Without loss of generality we consider a situation where all n individuals simulated have same entry time into the study. The study lasts 50 units of time. From the entry time, time to death T i , for each individual i, is simulated from a geometric distribution function with probability of success (death) equal to p 0 (X i ). The probability distribution of time to death is, thus, given by Pr(
. Similarly, we generate the time to treatment T and the average ∆ s (t).
with probability of success (treatment) p d (X i ). The probability distribution of time to treatment is then given by Pr(
We consider the following situations: a 0 = −3.0, b 0 = −5.5 and −3.0, and b 1 = a 1 are set either to 0 or 1. In the homogeneous case (i.e. b 1 = a 1 = 0) the death hazard if not treated is p 0 (X i ) = 0.047 and the hazards into treatment are p d (X i ) = 0.0041 and 0.047 respectively for b 0 = −6.5 and −3.0. The proportion of treated was on average equal to 2.9 and 49 per cent in these two simulated situations. These designs were chosen to resemble the situation encountered in the two applications described earlier: the employment subsidy where only 3% were treated and the Stanford heart transplant program where we had 67% of treated individuals. In the employment subsidy treatment the unconditional monthly hazard to death (employment in this application) if not treated is approximately constant, around 0.045. In the Stanford heart transplant program the daily unconditional hazard to death if not treated is decreasing: we obtained an unconditional hazard of 7%, 4%, 3% and 1% based on respectively the first 7 deaths, the first 13 deaths, the first 23 deaths, and on all 30 observed deaths. In order to keep the design simple and transparent we use a constant unconditional hazard of 0.047 in both simulations.
We further need to simulate a time to death T those individuals who are treated, i.e. such that
−1 . Finally, the X i 's are generated from a (0, 1) uniform distribution, and are fixed in repeated samples.
This simulation design can be related to the potential outcome framework of Section 3 as follows. The treatment assignment mechanism at time W i , D i (W i ), is given by A consequence is that the hazard h 0 (t; W ) is known while h 1 (t; W ) is not. We, therefore, choose to use their limit (letting the number of treated n 1 tend to infinity) in probability, h j (t; W ) p −→ h j (t; W ) as n 1 → ∞, j = 0, 1, to assess the quality of the estimators. We have
for n, the number of simulated design points, large enough. In particular, when a 1 = 0, h j (t; W ) = p j (X i ) = p j . Thus, we use ∆ s (t; W ) obtained by using h 1 (t; W ) and h 0 (t; W ) as an approximation of the estimand of interest ∆ s (t; W ). This approximation is used to compute the bias of the estimator ∆ s (t; W ) with 1,000 simulated replicates. This is reasonable because the difference h j (t; W ) − h j (t; W ), j = 0, 1, is zero on average (over the replicates).
In general, the hazard h 0 (t; W ) may depend on W . This is not the case here due to the choice of the geometric distribution for generating survival times. In this experiment we have, therefore, that the difference in hazards depends on W only through a w .
The no-treatment effect situation is obtained by letting
Situations with a non-zero treatment effect are designed for an homogeneous (a 1 = 0) and an heterogeneous (a 1 = 1) case as follows. We let a w = ln[{0.047 + (1/(W + 23))}/{1 − 0.047 − (1/(W + 23))}]. For the homogeneous case this yields the treatment effects ∆ h (t; 1) = 1/24 ∼ = 4.2%, ∆ h (t; 5) = 1/28 ∼ = 3.6%, ∆ h (t; 10) = 1/33 ∼ = 3.0%, ∆ h (t; 15) = 1/38 ∼ = 2.6%. Figure 4 displays the treatment effects ∆ s (t; W ) for these four values of W as well as for the average. The figure shows clearly that the treatment effect varies with W , getting smaller as waiting time goes.
Results
We study the bias of the estimator ∆ s (t; W ), where matching is performed as described in the applications, see Section 2. The continuous covariate x i is matched using the 
is also studied. We perform experiments, where the number of individuals are varied as n = 500, 1,500 and 6,000, and the number of replicates is 1,000.
To save space, we restrict the presentation of the results to the setting with covariates (i.e. a 1 = b 1 = 1). For the bias study, we show results for the case with a treatment effect (i.e. a w = 0). The non-reported cases gave a similar picture to those reported. We start by presenting the case with 2.9% treated. Thereafter, results for the situation with 49% treated are commented. The results are displayed in figures with panels ordered from left to right with respect to sample size and from bottom to top with respect to W, except for the panels on the first row, where the results for the average estimator/test are displayed.
The case with 2.9 percent treated
The bias of the estimator and the size and power of the test of no treatment effect are presented in Figures 5, 6 and 8, respectively. In this setting, the number of treated equals on average 14.5, 44 and 174 when the sample size equal 500, 1, 500 and 6, 000, respectively. For W = 1 and 15 the corresponding figures are 1.63, 3.37 and 9.13 and 1.18, 1.57 and 4.01, respectively.
The bias ( Figure 5 ) is, as expected, decreasing with sample size n. Considering the relatively small sample sizes of treated for each W the estimator does well. The size of the Wald test is displayed in Figure 6 . For sample sizes 1,500 and 2,500 the average estimator have approximately correct size. For the conditional estimator the size is too small for small n and too large when n = 6, 000 and W > 5. Considering the extremely few number of treated for each W these results are perhaps not surprising. When extending the sample size to 12, 000 the correct size is well approximated for all values of W. The power of the Wald test is displayed in Figure 8 . As expected the Wald test has significant power only for the average effects, due to the low number of treated individuals in each sub-group defined by W .
The case with 49 percent treated
The bias of the estimator, and the size and power of the test of no treatment effect are presented in Figures 7, 9 and 10, respectively. In this setting the number of treated is for sample size of 500, 1, 500 and 6, 000 on average 240, 718 and 2,876, respectively. For W = 1 and 15 the corresponding figures are 30, 90 and 363 and 4, 10 and 39, respectively. The bias displayed in Figure 7 is positive however decreasing with n. The size of the Wald test is displayed in Figure 9 . There is a small tendency of too large size when n Figure 6: Empirical size (nominal size 5 %) for the matching estimator in the heterogeneous treatment setting (i.e. a 1 = b 1 = 1 and a w = 0) with proportion of treated equal to 2.9%. Empirical sizes above the horizontal dotted line (6.4%) are significantly higher (at a 2.5% level of significance) than the nominal size of 5%.
is small for the conditional estimator. The average estimator always displays too large a size. Larger sample sizes do not help in this situation. Because the fraction of treated is large and constant, this result should be expected. The power of the Wald test is displayed in Figure 10 . It increases with n. The power of the test for the average case is not comparable to the others due to the size failure.
Concluding discussion
In this paper we study non-parametric estimators for the effect of a treatment on a survival outcome. The effect (estimand) is a difference of survival functions computed on two groups of matched individuals (treated and control). The methods introduced are best suited for observational studies including many individuals. Such large observational studies allows us to relax restrictive assumptions such as parametric functional forms, proportionality of the hazards, and homogeneity of the hazards with respect to waiting time until treatment. To avoid assumptions of constant hazard with respect to waiting time until treatment we propose to perform inference conditionally on waiting time, when the number of treated individuals at each waiting time of interest is large enough. Otherwise, one may average over waiting times. In the latter case, the estimated treatment effect does not keep necessarily its interpretation of a difference of survival functions, although one may still test the hypothesis of no treatment effect.
The variance estimator we provide is in general conservative unless there is zero constant additive treatment effect. Hence, the null hypothesis of zero constant additive treatment effect can be tested with correct size with a Wald statistic. This is true under the Neyman inferential framework used herein but also under a classical frequentist setting if the observed sample has been randomly drawn from a population of interest. When this null hypothesis does not hold our estimator is still unbiased but its Neyman inference is conservative. Our simulation results have confirmed these theoretical insights. They have also shown that the Wald test has power, although, it is essential to observe enough treated individuals at a given waiting time, when conditioning the inference on the latter.
An application on an employment subsidy to shorten unemployment duration shows the applicability of the proposed matching estimator. Although our applications did not include time-dependent covariates, such situations are straightforward to handle when conditioning the inference on waiting time, thereby making the time dependence of the covariates obsolete. Note, finally, that the matching estimators studied herein could also make use of Rosenbaum and Rubin (1983) results, by matching on Pr(D(W ) = 1|X) −the propoensity score− instead of X. This is often advocated in the matching literature, for instance, when X includes many continuous covariates in order to diminish the bias due to poor matches. Figure 9: Empirical size (nominal size 5%) for the matching estimator in the heterogeneous treatment setting (i.e. a 1 = b 1 = 1 and a w = 0) with proportion of treated equal to 49%. Empirical sizes above the horizontal dotted line (6.4%) are significantly higher (at a 2.5% level of significance) than the nominal size of 5%.
Appendix: Sampling properties of ∆ h (t; W )
Sampling scheme
We adapt the sampling model of Neyman (1990) to our context. Let us consider two urns representing each one of the two potential outcomes. For a given time W , urn j, j = 0, 1, contains the potential outcomes (possibly censored) T j i (W ) for i = 1, . . . , 2n 1 , the n 1 matched pairs that have survived up to time W . At a given time t > W , the elements in the urns are of three different types: (×) those who have died or have been censored before time t (T j i (W ) < t or censored before t, j = 0, 1), (0) those who have not been censored until time t and die at time t (T j i (W ) = t, j = 0, 1) and (1) those who have survived and have not been censored up to time t (T j i (W ) ≥ t, j = 0, 1). Denote by m j × (t), m j 0 (t), and m j 1 (t), respectively, the number of elements in the three categories for the two urns j = 0, 1.
These two urns describe the population in the inferential framework adopted in this paper. From this population, at the beginning of the sub-study conditional on waiting time W , we sample without replacement n 1 individuals from one of the urn. Each time one individual is sampled, say from the urn with the treated potential outcome, the non-treated potential outcome corresponding to the same unit is also removed from the other urn. Assume that n 1 individuals are drawn without replacement from urn j, and define by ).
Unbiasedness
We show here the unbiasedness of ∆ h (t; W ) for ∆ h (t; W ), i.e. E{ ∆ h (t; W )} = ∆ h (t; W ), where the expectation operator is defined by the sampling scheme described above. Note that h j (t; W ) = X j Y j , j = 0, 1. Then, using the distribution identified above we have E{ h 1 (t; W )} = E(X 1 /Y 1 ) Hence, E{ ∆ h (t; W )} = ∆ h (t; W ).
Variance
We want to estimate V ar{ h 1 (t; W ) − h 0 (t; W )}. We have
The last equality follows because E(X 1 /Y 1 − X 0 /Y 0 |Y 1 , Y 0 ) is constant; see previous section. By the same arguments used in Neyman (1990) −see also Rubin (1990a, Eq. 2)− we can write
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This is, in particular, due to the fact that h j (t; W ){1 − h j (t; W )} is the usual variance estimator based on a sample of size Y j , j = 0, 1. Note that for us to be able to use the results of Neyman is an unbiased estimator of V ar{ h 1 (t; W ) − h 0 (t; W )} when S 2 =0, that is, for instance, when T 1 i (W ) = T 0 i (W ), for i = 1, . . . , 2n 1 . In general, the estimator of the variance is positively biased.
